388 related articles for article (PubMed ID: 25200152)
1. [Mouse macrophage-derived chemokine as an adjuvant enhances the protective effect of P6 protein vaccine of nontypeable Haemophilus influenzae].
Han X; Wang C; Qiao H; Zhang Y; Chang Y; Zhang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):913-6. PubMed ID: 25200152
[TBL] [Abstract][Full Text] [Related]
2. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity.
McMahon M; Murphy TF; Kyd J; Thanavala Y
Vaccine; 2005 May; 23(27):3590-6. PubMed ID: 15855018
[TBL] [Abstract][Full Text] [Related]
3. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide.
Noda K; Kodama S; Umemoto S; Nomi N; Hirano T; Suzuki M
Microbiol Immunol; 2011 Aug; 55(8):574-81. PubMed ID: 21605159
[TBL] [Abstract][Full Text] [Related]
4. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
[TBL] [Abstract][Full Text] [Related]
5. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
[TBL] [Abstract][Full Text] [Related]
6. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx.
Abe N; Kodama S; Hirano T; Eto M; Suzuki M
Laryngoscope; 2006 Mar; 116(3):407-12. PubMed ID: 16540899
[TBL] [Abstract][Full Text] [Related]
7. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
Bertot GM; Becker PD; Guzmán CA; Grinstein S
J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
[TBL] [Abstract][Full Text] [Related]
8. Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx.
Noda K; Kodama S; Umemoto S; Abe N; Hirano T; Suzuki M
Vaccine; 2010 Jul; 28(31):5068-74. PubMed ID: 20478344
[TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
Sabirov A; Kodama S; Hirano T; Suzuki M; Mogi G
Infect Immun; 2001 May; 69(5):2964-71. PubMed ID: 11292713
[TBL] [Abstract][Full Text] [Related]
10. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Kodama S; Hirano T; Noda K; Abe N; Suzuki M
Vaccine; 2010 Mar; 28(13):2510-6. PubMed ID: 20117272
[TBL] [Abstract][Full Text] [Related]
11. Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.
Hua CZ; Hu WL; Shang SQ; Li JP; Hong LQ; Yan J
Clin Vaccine Immunol; 2016 Feb; 23(2):155-61. PubMed ID: 26677200
[TBL] [Abstract][Full Text] [Related]
12. In silico design, cloning, expression and immunologic evaluation of ED fusion protein of NT H. influenzae.
Behrouzi A; Bouzari S; Oloomi M; Fateh A; Vaziri F; Afrough P; Amanzadeh A; Siadat SD
Microb Pathog; 2017 Dec; 113():472-479. PubMed ID: 29138085
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
Khan MN; Kaur R; Pichichero ME
FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
[TBL] [Abstract][Full Text] [Related]
14. Recombinant C-terminal 311 amino acids of HapS adhesin as a vaccine candidate for nontypeable Haemophilus influenzae: A study on immunoreactivity in Balb/C mouse.
Tabatabaee Bafroee AS; Siadat SD; Mousavi SF; Aghasadeghi MR; Khorsand H; Nejati M; Sadat SM; Mahdavi M
Microb Pathog; 2016 Sep; 98():106-11. PubMed ID: 27377430
[TBL] [Abstract][Full Text] [Related]
15. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
[TBL] [Abstract][Full Text] [Related]
16. Preparation and immunogenicity evaluation of C-HapS-P6 fusion protein vaccine against nontypeable Haemophilus influenzae in mice.
Hu N; Li W; Zhao Z; Chang Y; Wang C; Zhang Y
Int J Med Microbiol; 2024 Mar; 314():151616. PubMed ID: 38461565
[TBL] [Abstract][Full Text] [Related]
17. Maternal intranasal immunization with outer membrane protein P6 maintains specific antibody level of derived offspring.
Yamauchi K; Hotomi M; Billal DS; Suzumoto M; Yamanaka N
Vaccine; 2006 Jun; 24(25):5294-9. PubMed ID: 16697503
[TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae.
Hotomi M; Yamanaka N; Shimada J; Suzumoto M; Ikeda Y; Sakai A; Arai J; Green B
Int J Pediatr Otorhinolaryngol; 2002 Sep; 65(2):109-16. PubMed ID: 12176180
[TBL] [Abstract][Full Text] [Related]
19. Immunization of mice with P6 of nontypeable Haemophilus influenzae: kinetics of the antibody response and IgG subclasses.
Badr WH; Loghmanee D; Karalus RJ; Murphy TF; Thanavala Y
Vaccine; 1999 Aug; 18(1-2):29-37. PubMed ID: 10501232
[TBL] [Abstract][Full Text] [Related]
20. Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6.
Yang YP; Munson RS; Grass S; Chong P; Harkness RE; Gisonni L; James O; Kwok Y; Klein MH
Vaccine; 1997 Jun; 15(9):976-87. PubMed ID: 9261944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
